SGC-BRDVIII-NC

Overview

SGC-BRDVIII-NC (Compound 35) is a negative control compound of SMARCA2/4 and PB1 bromodomain (BRD) inhibitor. SGC-BRDVIII-NC completely abolishes protein-ligand binding capacity with the methylation of the phenolic hydroxyl moiety. SGC-BRDVIII-NC can be used for adipogenesis research.

Application

Products | Products > Disease Areas > Others | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Others | Products > Signaling Pathways > Epigenetic Reader Domain | Products > Signaling Pathways > SWI/SNF Complex

Product Information

• Catalog No.: HY-176822
• CAS No.: 2650530-02-0
• Molecular Formula: C20H27N5O3
• Molecular Weight: 385.46
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source